Original Research

Published on 24 Oct 2022

Identification of biomarkers for hepatocellular carcinoma based on single cell sequencing and machine learning algorithms

in Cancer Genetics and Oncogenomics

Weimin Li
Jixing Liu
Wenjuan Zhu
Xiaoxin Jin
Zhi Yang
Wenzhe Gao
Jichun Sun
Hongwei Zhu

Frontiers in Genetics

doi 10.3389/fgene.2022.873218

3,154 views
2 citations

Original Research

Published on 24 Oct 2022

High expression of MARVELD3 as a potential prognostic biomarker for oral squamous cell carcinoma

in Cancer Genetics and Oncogenomics

Ke Huang
Yucheng Meng
Jiyuan Lu
Lingdan Xu
Shiqi Wang
Huihui Wang
Zhaoqing Xu

Frontiers in Genetics

doi 10.3389/fgene.2022.1050402

1,906 views
2 citations

Original Research

Published on 24 Oct 2022

Novel IKZF3 transcriptomic signature correlates with positive outcomes of skin cutaneous melanoma: A pan-cancer analysis

in Cancer Genetics and Oncogenomics

Lin-Kai Yang
Can-Xiang Lin
Sheng-Hong Li
Jia-Ji Liang
Li-Ling Xiao
Guang-Hui Xie
Hong-Wei Liu
Xuan Liao

Frontiers in Genetics

doi 10.3389/fgene.2022.1036402

3,342 views
2 citations

Original Research

Published on 24 Oct 2022

A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma

in Cancer Genetics and Oncogenomics

Jiasheng Zhong
Jie Liu
Zhilin Huang
Yaofeng Zheng
Jiawen Chen
Jingsen Ji
Taoliang Chen
Yiquan Ke

Frontiers in Genetics

doi 10.3389/fgene.2022.1026192

2,462 views
1 citation

Original Research

Published on 21 Oct 2022

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma

in Cancer Genetics and Oncogenomics

Yifan Xu
Chao Wang
Shifang Li
Han Zhou
Yugong Feng

Frontiers in Genetics

doi 10.3389/fgene.2022.975419

3,646 views
5 citations

Original Research

Published on 21 Oct 2022

Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma

in Cancer Genetics and Oncogenomics

Ming Sun
Shanshan Qi
Min Wu
Wei Xia
Hao Xiong

Frontiers in Genetics

doi 10.3389/fgene.2022.909556

2,950 views
5 citations

Review

Published on 21 Oct 2022

Light at the end of the tunnel: Clinical features and therapeutic prospects of KRAS mutant subtypes in non-small-cell lung cancer

in Cancer Genetics and Oncogenomics

Liyuan Gao
Weizhang Shen

Frontiers in Genetics

doi 10.3389/fgene.2022.890247

8,827 views
5 citations

Original Research

Published on 21 Oct 2022

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma

in Cancer Genetics and Oncogenomics

Fan Ye
Pingan Wu
Yaqiong Zhu
Guan Huang
Ying Tao
Zhencheng Liao
Yafeng Guan

Frontiers in Genetics

doi 10.3389/fgene.2022.989081

2,545 views
3 citations

Original Research

Published on 21 Oct 2022

A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survival

in Cancer Genetics and Oncogenomics

Carlos A. Barrón-Gallardo
Mariel Garcia-Chagollán
Andres J. Morán-Mendoza
Raul Delgadillo-Cristerna
María G. Martínez-Silva
María M. Villaseñor-García
Adriana Aguilar-Lemarroy
Luis F. Jave-Suárez

Frontiers in Genetics

doi 10.3389/fgene.2022.991706

5,479 views
7 citations

Original Research

Published on 21 Oct 2022

Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy

in Cancer Genetics and Oncogenomics

Wei Wei
Chao Liu
Caihong Wang
Meng Wang
Wei Jiang
Yaqian Zhou
Shuqun Zhang

Frontiers in Genetics

doi 10.3389/fgene.2022.1016797

4,823 views
2 citations

Original Research

Published on 20 Oct 2022

Peripheral blood markers predict immunotherapeutic efficacy in patients with advanced non-small cell lung cancer: A multicenter study

in Cancer Genetics and Oncogenomics

Shuai Liu
Liuyuan Zhao
Guohua Zhou

Frontiers in Genetics

doi 10.3389/fgene.2022.1016085

1,708 views
6 citations

Original Research

Published on 20 Oct 2022

Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation

in Cancer Genetics and Oncogenomics

Xinyu Zhang
Xinyue Qin
Tiannan Yu
Kexin Wang
Yinhao Chen
Qianwei Xing

Frontiers in Genetics

doi 10.3389/fgene.2022.974726

1,959 views
7 citations

Original Research

Published on 20 Oct 2022

Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation

in Cancer Genetics and Oncogenomics

Hannah G. Daniels
Breanna G. Knicely
Anna Kristin Miller
Ana Thompson
Rina Plattner
Eva M. Goellner

Frontiers in Genetics

doi 10.3389/fgene.2022.940073

3,063 views

Original Research

Published on 20 Oct 2022

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma

in Cancer Genetics and Oncogenomics

Kai Gan
Keying Zhang
Yu Li
Xiaolong Zhao
Hongji Li
Chao Xu
Shaojie Liu
Chao Zhang
Donghui Han
Weihong Wen

Frontiers in Genetics

doi 10.3389/fgene.2022.1021163

2,783 views
1 citation

Original Research

Published on 20 Oct 2022

An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy

in Cancer Genetics and Oncogenomics

Xinghe Liao
Hui Liu
Zhe Zhang
Jing Zhang
Chenyue Zhang
Weiwei Zhao

Frontiers in Genetics

doi 10.3389/fgene.2022.1010787

1,752 views
5 citations

Original Research

Published on 20 Oct 2022

Identification of a prognostic risk-scoring model and risk signatures based on glycosylation-associated cluster in breast cancer

in Cancer Genetics and Oncogenomics

Shengnan Gao
Xinjie Wu
Xiaoying Lou
Wei Cui

Frontiers in Genetics

doi 10.3389/fgene.2022.960567

1,925 views
1 citation

Navigation group

Articles

Identification of biomarkers for hepatocellular carcinoma based on single cell sequencing and machine learning algorithms

High expression of MARVELD3 as a potential prognostic biomarker for oral squamous cell carcinoma

Novel IKZF3 transcriptomic signature correlates with positive outcomes of skin cutaneous melanoma: A pan-cancer analysis

A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma

Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma

Light at the end of the tunnel: Clinical features and therapeutic prospects of KRAS mutant subtypes in non-small-cell lung cancer

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma

A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survival

Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy

Peripheral blood markers predict immunotherapeutic efficacy in patients with advanced non-small cell lung cancer: A multicenter study

Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation

Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma

An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy

Identification of a prognostic risk-scoring model and risk signatures based on glycosylation-associated cluster in breast cancer